中西药联合佐治糖尿病周围神经病变的临床观察被引量：5

The Clinical Observation of Treating Diabetic Perineuropathy by Integrated Tcm-wm

导出

摘要目的:观察丹红注射液与甲钴胺联合治疗糖尿病周围神经病变(DPN)的疗效。方法:将64例DPN患者随机分为两组,观察组给予丹红注射液和甲钴胺联合治疗,疗程3周:对照组仅用甲钴胺治疗,疗程3周。结果:观察组总有效率86.3%优于对照组的52.9%,两组比较差异显著(P<0.05)。结论:丹红注射液联合甲钴胺治疗DPN疗效确切,结合正确的护理措施,可明显改善DPN的临床症状。 Objective：This thesis observed the effect of the patients of diabetic perineuropathy （DPN） treated by Meeobalamin plus Danhong injection. Methods：It was divided randomly to treatment group and control group about the 64 patients of DPN. The control group was treated by using Meeobalamin only, the treatment group was used same method besides Danhong injection, the course of treatment was 3 weeks.Results：The treatment group＇s total effective rate was 86.3%, the control group＇s total effective rate was 52.9% .As compared with the control group, the treatment group had significance distinction （P〈0.05）.Conclusion：It was certain to treat DPN by Mecobalamin plus Danhong injection, it would improve clinical symptoms of the DPN obviously and united perfect nursing intervention.

作者郭艳宏陈宏王久英

机构地区牡丹江医学院红旗医院内分泌科

出处《中国医药导刊》 2010年第6期988-989,共2页 Chinese Journal of Medicinal Guide

关键词丹红注射液甲钴胺糖尿病周围神经病变 Danhong injection Mecobalamin Diabetic Perineuropathy

分类号 R544.1 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献2

1Greene DA.Sima AAF.Stevens MJ.el al.Complications:Neuropathy pathogenetie Considerations[J].diabetes Care,1992;15(1):1902.
2张国华,廖晓凌,林杰,张晓炜.糖尿病性神经病发病机制研究进展[J].临床荟萃,2003,18(21):1247-1248. 被引量：40

二级参考文献15

1Cameron N E,Eaton S E,Cotter M A, et al . Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy[J]. Diabetologia, 2001,44(11) : 1973-1988.
2Haler M C, Ivey F M, Gyure K A, et al. Thrombomodulin deficiency in human diabetic nerve microvasculature [J]. Diabetes, 2002,51(6): 1957-1963.
3Aso Y, Fujiwara Y, Tayama K, a al. Elevation of von Willebrand factor in plasma in diabetic patients with neuropathic foot ulceration[J]. Diabet Med, 2002,19(1) : 19-26.
4Nakayama M, Nakamaru J, Hamada Y, a al . Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy[J]. Diabetes Care,2001,24(6) : 1093-1098.
5Zochodne D W. Diabetic neuropathies : features and mechanisms[J]. Brain Pathol,1999,9(2) :369-391.
6Verrotti A,Giuva P T, Morgese G, et al . New trends in the etipathogenesis of diabetic peripheral neuropathy[J]. J Child Neurol, 2001,16(6) : 389-394.
7Conti G, Scarpini E, Baron P, mal . Macrophage infiltration and death in the nerve during the early phases of experimental diabetic neuropathy: a process concomitant with endoneurial induction of IL-lbeta and p75NTR[J]. J Neurol Sci, 2002,195(1) : 35-40.
8Skundric D S, Dai R, James J, mal. Activation of IL-1 signaling pathway in Schwann cells during diabetic neuropathy [J]. AnnNYAcadSci, 2002,958(2): 393-398.
9Rask C A. Biological actions of nerve growths factors in the peripheral nervous system[J]. Eur neurol, 1999,41( Supple 1) :14-19.
10Femyhough P, Diemel L T, Tomlinson D R, a al. Target tissue production and axonal transport of neurotrophin-3 are reduced in steptozotocin-dibetic rats[J]. Diabetologia,1998,41(3) :300-306.